JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2008; 106:101-108
© 2008 International Anesthesia Research Society
doi: 10.1213/01.ane.0000289526.20117.26
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathews, D. M.
Right arrow Articles by Neuman, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathews, D. M.
Right arrow Articles by Neuman, G. G.
Related Collections
Right arrow Ambulatory
Right arrow Anesthetic Techniques
Right arrow Clinical Pharmacology
Right arrow Pharmacology


AMBULATORY ANESTHESIOLOGY

Can Remifentanil Replace Nitrous Oxide During Anesthesia for Ambulatory Orthopedic Surgery with Desflurane and Fentanyl?

Donald M. Mathews, MD, Vijay Gaba, MD, Bledi Zaku, BS, and George G. Neuman, MD

From the Department of Anesthesiology, St. Vincent Catholic Medical Centers, St. Vincent’s Manhattan, and New York Medical College, Valhalla, New York.

Address correspondence and reprint requests to Donald M. Mathews, MD, Department of Anesthesiology, St Vincent’s Hospital, 170 West 12th St., NR 408, New York, NY 10011. Address e-mail to dmathews{at}svcmcny.org.

Abstract

BACKGROUND: The administration of nitrous oxide (N2O) may be associated with side effects and toxicities. Remifentanil shares characteristics with N2O, including MAC-reducing and antinociceptive effects and a rapid decrease in clinical effect when discontinued. We compared the outcome after ambulatory orthopedic surgery with desflurane and fentanyl supplemented with clinically equivalent doses of either N2O or remifentanil.

METHODS: Seventy patients undergoing ambulatory orthopedic surgery were studied. Thirty-five received 66% N2O and 35 received remifentanil 0.085 µg · kg–1 · min–1 in addition to desflurane, titrated to a bispectral index (BIS) value of 50, and a fentanyl infusion. The principle outcome measure was time to awakening to verbal stimulation. Secondary outcome measures included neuropsychological testing, time to orientation, hemodynamic values, pain and nausea visual analog scores, discharge times, and satisfaction scores. The average end-tidal desflurane concentration and fentanyl effect-site concentration were determined.

RESULTS: The median time (interquartile range) to awakening to verbal stimulation, 3.0 min (3.0–5.0 min) in the remifentanil group and 4.6 min (3.0–8.1 min) in the N2O group was not significantly different. Median time to orientation was significantly faster in the remifentanil group: 6.0 min (5.0–8.5 min) compared with 8.0 min (5.0–12.8 min) for the N2O group. There was no difference between groups in desflurane or fentanyl administration, neuropsychological testing, or any other outcome measure.

CONCLUSIONS: This study demonstrates that a remifentanil infusion of 0.085 µg · kg–1 · min–1 may be substituted for 66% N2O during desflurane/fentanyl anesthesia without any clinically significant change in outcome.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2008 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2008 by the International Anesthesia Research Society.